Clinical trials
Terminated Phase 2 Kidney Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Goldfinch Bio, Inc. | 2 |
| Aravive, Inc. | 1 |
| Astellas Pharma Inc | 1 |
| Dynavax Technologies Corporation | 1 |
| Genfit | 1 |
| Genzyme, a Sanofi Company | 1 |
| Mario Negri Institute for Pharmacological Research | 1 |
| NiKang Therapeutics, Inc. | 1 |
| SymBio Pharmaceuticals | 1 |
| University of Alabama at Birmingham | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Diseases | 14 |
| Glomerulonephritis | 3 |
| Nephritis | 3 |
| Urologic Diseases | 3 |
| Nephrosis | 2 |
| Proteinuria | 2 |
| Renal Insufficiency | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Acute-On-Chronic Liver Failure | 1 |
| Adenocarcinoma | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.